癌症GREM1研究的现状和前景 (综述)
Dantong Zhu1, Dong Zhao1, Naixue Wang2
1Department of Medical Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110000, P.R. China.
Molecular and clinical oncology
|August 24, 2023
概括
格雷姆林1 (GREM1) 是一种蛋白质,在癌症中具有多种作用,促进某些瘤,同时抑制胰腺癌等其他瘤. 使用单细胞测序的进一步研究可能会澄清其诊断和预后潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 格雷姆林1 (GREM1) 是一种被分泌的蛋白质,参与胚胎发育和组织分化.
- GREM1对抗骨形态遗传蛋白 (BMP) 并抑制转化生长因子-β (TGF-β).
- GREM1作为血管内皮生长因子受体2的连接体,并影响表皮-介质细胞过渡.
研究的目的:
- 审查格雷姆林1 (GREM1) 在各种瘤的发展和进展中的多方面的作用和功能.
- 探索GREM1在癌症中的双重功能,在一些癌症中起促进作用,在其他癌症中起抑制作用.
- 评估GREM1作为瘤学诊断和预后生物标志物的潜力.
主要方法:
- 关于格雷姆林1 (GREM1) 在不同癌症类型中的表达和功能现有文献的综述.
- 对GREM1参与信号通路的分析,包括BMP和TGF-β.
- 检查GREM1对表皮细胞-介质细胞过渡和瘤转移的影响.
主要成果:
- GREM1在各种瘤类型中表达,并影响上皮层-介质细胞转化.
- 在乳腺癌和结肠癌中,GREM1通常促进瘤的进展.
- 相反,在胰腺癌中,GREM1过度表达抑制了瘤转移,表明了取决于背景的作用.
结论:
- 格雷姆林1 (GREM1) 具有复杂和癌症特异性的功能,既起瘤基因作用,又起瘤抑制作用.
- GREM1作为各种恶性瘤的潜在诊断和预后指标具有前景.
- 未来使用单细胞测序技术的研究对于更深入地了解GREM1在瘤中的精确作用至关重要.
相关概念视频
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K